COVID-19’un Klinik Yönetimi ve Hemşirelik

demirağ, hatice; HİNTİSTAN, sevilay

COVID-19’un Klinik Yönetimi ve Hemşirelik

Hatice DEMİRAĞ, (Gümüşhane Üniversitesi, Tıbbi Hizmetler ve Teknikler Bölümü, İlk ve Acil Yardım Programı, Gümüşhane, Türkiye)

Sevilay HİNTİSTAN (Karadeniz Teknik Üniversitesi, Sağlık Bilimleri Fakültesi, İç Hastalıkları Hemşireliği Anabilim Dalı, Trabzon, Türkiye)

Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi

2 0

Yıl: 2020 Cilt: 9 Sayı: 2 Sayfa Aralığı: 222 - 231 Metin Dili: Türkçe İndeks Tarihi: 01-11-2020

COVID-19’un Klinik Yönetimi ve Hemşirelik

Öz:

“COVID-19” hastalığı, Dünya Sağlık Örgütü(DSÖ) tarafından 11 Mart 2020 tarihinde pandemiolarak ilan edilen ve ciddi akut solunum sendromukoronavirüs 2'nin (SARS-CoV-2) neden olduğubulaşıcı bir hastalıktır. Dünya genelinde hızla yayılanCOVID-19 salgını her geçen gün morbitide vemortalite sayısının artmasına neden olmaktadır. Hastaile en çok temas eden hemşireler, hastalığın klinikyönetiminde ve enfeksiyonun önlenmesinde önemliderecede rol almaktadırlar. Bu derlemenin amacı,COVID-19’un risk faktörleri, bulaş yolu, tanı, tedavihakkında bilgi vermek, klinik semptomlarıtanımlamak ve COVID-19 enfeksiyonu ile hastaneyebaşvuran hastaların klinik yönetiminde optimumhemşirelik yönetimini tartışmaktır.

Anahtar Kelime:

Clinical Management and Nursing of COVID-19

Öz:

“COVID-19” disease is an infectious disease that was declared as a pandemic by the World Health Organization (WHO) on March 11, 2020 and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The COVID-19 epidemic, which is spreading worldwide, causes morbidity and mortality increase day by day. Nurses who have the most contact with the patient play an important role in clinical management of the disease and prevention of infection. The purpose of this review is to provide information about the risk factors, transmission route, diagnosis and treatment of COVID-19, to identify clinical symptoms, and to discuss optimal nursing management in the clinical management of patients admitted to the hospital with COVID-19 infection.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

1. Tomasi DL. Coronavirus disease (COVID-19). A socioepidemiological analysis. Bennington, VAAT: Vermont Academy of Arts and Sciences LV (I), 2020; (1): p.1-5. https://www.researchgate.net/publication/339936638.
2. Salute MD. Nuovo Coronavirus. Roma, I: Governo-Repubblica Italiana, 2020. http://www.salute.gov.it/nuovocoronavirus. (Erişim Tarihi: 26.03.2020).
3. De Rio C, Malani PN. Novel Coronavirus-Important Information for Clinicians. JAMA, 2020; 323(11): 1039-40. doi:10.1001/jama.2020.1490.
4. Salute MD. COVID-19- Situazione in Italia. Roma, I: GovernoRepubblica Italiana, 2020. http://www.salute.gov.it/portale/nuovocoronavirus/dettaglioCo ntenutiNuovoCoronavirus.jsp?lingua=italiano&id=5351&area= nuovoCoronavirus&menu=vuoto. (Erişim Tarihi: 26.03.2020).
5. World Health Organization (WHO). Coronavirus disease (COVID-19) outbreak situation, 2020. https://www.who.int/emergencies/diseases/novel-coronavirus2019. (Erişim Tarihi: 24.06.2020).
6. T.C. Sağlık Bakanlığı. Türkiye’deki güncel durum: Türkiye genel koronavirüs tablosu, 2020. https://COVID19.saglik.gov.tr/. (Erişim Tarihi: 31.03.2020).
7. Centers for Disease Control and Prevention (CDC). Coronavirus Disease 2019 (COVID-19): Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID19) in Healthcare Settings, 2020. https://www.cdc.gov/coronavirus/2019-ncov/infectioncontrol/controlrecommendations.html?CDC_AA_refVal=https%3A%2F%2F www.cdc.gov%2Fcoronavirus%2F2019- ncov%2Fhcp%2Finfection-control.html. (Erişim Tarihi: 27.03.2020).
8. World Health Organization (WHO). Coronavirus, 2020. https://www.who.int/health-topics/coronavirus#tab=tab_1. (Erişim Tarihi: 27.03.2020).
9. Centers for Disease Control and Prevention (CDC). Coronavirus Disease 2019 (COVID-19): Who is at risk for severe disease from COVID-19?, 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/faq.html. (Erişim Tarihi: 27.03.2020).
10. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi, 2020; 41(2): 145- 51. DOI:10.3760/cma.j.issn.0254-6450.2020.02.003.
11. Kam KQ, Yung CF, Cui L, et al. A Well Infant with Coronavirus Disease 2019 (COVID-19) with High Viral Load. Clin Infect Dis, 2020 Feb 28. pii: ciaa201. doi: 10.1093/cid/ciaa201. [Epub ahead of print].
12. Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang ZJ. Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China. JAMA, 2020 Feb 14. doi: 10.1001/jama.2020.2131. [Epub ahead of print].
13. Chen F, Liu ZS, Zhang FR, et al. First case of severe childhood novel coronavirus pneumonia in China. Zhonghua Er Ke Za Zhi, 2020 Feb 11; 58(0): E005. doi: 10.3760/cma.j.issn.0578- 1310.2020.0005. [Epub ahead of print].
14. Centers for Disease Control and Prevention (CDC). Coronavirus Disease 2019 (COVID-19): What Healthcare Personnel Should Know about Caring for Patients with Confirmed or Possible COVID-19 Infection, 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-forpatients.html. (Erişim Tarihi: 27.03.2020).
15. Centers for Disease Control and Prevention (CDC). How Coronavirus Spreads, 2020. https://www.cdc.gov/coronavirus/2019-ncov/prevent-gettingsick/how-COVID-spreads.html. (Erişim Tarihi: 28.03.2020).
16. Guan WJ, Ni ZY, Hu Y, et al. China Medical Treatment Expert Group for COVID-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med, 2020 Feb 28: p.1-13. doi: 10.1056/NEJMoa2002032. [Epub ahead of print].17. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet,2020; 395 (10223), 497-506. DOI:https://doi.org/10.1016/S0140-6736(20)30183-5.
18. Wang D, Hu B, Hu C, et al. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel CoronavirusInfected Pneumonia in Wuhan. JAMA,2020; 323 (11), 1061- 69. doi:10.1001/jama.2020.1585.
19. Chan JF, Yuan S, Kok K, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating personto-person transmission: A Study of a family cluster. The Lancet, 2020; 395(10223): 514-23. DOI: 10.1016/S0140- 6736(20)30154-9.
20. Holshue ML, DeBolt C, Lindquist S, et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med, 2020; 382, 929-36. doi: 10.1056/NEJMoa2001191.
21. Chen N, Zhou M, Dong X, Qu J, Gong F. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet , 2020; 395 (10223), 507-13. DOI: 10.1016/S0140- 6736(20)30211-7.
22. Hoehl S, Berger A, Kortenbusch M, et al. Evidence of SARSCoV-2 Infection in Returning Travelers from Wuhan, China. New England Journal of Medicine. N Engl J Med, 2020; 382 (13): 1278-80. DOI: 10.1056/NEJMc2001899.
23. Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med, 2020; 382 (13), 1199-207. DOI: 10.1056/NEJMoa2001316.
24. Chen W, Lan Y, Yuan X, et al. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg Microbes Infect, 2020; 9 (1), 469-73. DOI: 10.1080/22221751.2020.1732837.
25. Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis, 2020; 20, 425–34. doi: 10.1016/S1473-3099(20)30086-4.
26. Zou L, Ruan F, Huang M, et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med, 2020; 382 (12), 1177-9. doi: 10.1056/NEJMc2001737.
27. Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic Features and Clinical Course of Patients Infected With SARSCoV-2 in Singapore. JAMA, 2020; 323(15), 1488-94. doi: 10.1001/jama.2020.3204.
28. Xia J, Tong J, Liu M, Shen Y, Gou D. Evaluation of coronavirus tears and conjunctival secretions of patient with SARS-CoV-2 infection. J Med Virol, 2020, p.1-6. https://doi.org/10.1002/jmv.25725.
29. Centers for Disease Control and Prevention (CDC). Coronavirus Disease 2019 (COVID-19): Highlights of CDC’s Response, 2020. https://www.cdc.gov/coronavirus/2019- ncov/cases-updates/summary.html#anchor_1582494216224. (Erişim Tarihi: 29.03.2020).
30. Yu L, Wu S, Hao X, et.al. Rapid colorimetric detection of COVID-19 coronavirus using a reverse transcriptional loopmediated isothermal amplification (RT-LAMP) diagnostic platform: iLACO. MedRxiv, 2020 February 24. doi: https://doi.org/10.1101/2020.02.20.20025874. [Epub ahead of print].
31. Centers for Disease Control and Prevention (CDC). Coronavirus Disease 2019 (COVID-19): Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19), 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinicalcriteria.html. (Erişim Tarihi: 29.03.2020).
32. Centers for Disease Control and Prevention (CDC). Coronavirus Disease 2019 (COVID-19): Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19), 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinicalguidance-management-patients.html. (Erişim Tarihi: 29.03.2020).
33. Centers for Disease Control and Prevention (CDC). Coronavirus Disease 2019 (COVID-19): Information for Clinicians on Therapeutic Options for COVID-19 Patients, 2020. https://www.cdc.gov/coronavirus/2019- ncov/hcp/therapeutic-options.html. (Erişim Tarihi: 29.03.2020).
34. Wang M, Cao R, Zhang L, et al. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res, 2020; 30 (3), 269- 71. doi: 10.1038/s41422-020-0282-0.
35. Yao X, Ye F, Zhang M, et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis, 2020 Mar 9. pii: ciaa237. doi: 10.1093/cid/ciaa237. [Epub ahead of print].
36. Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe COVID-19. N Engl J Med, 2020 March 18, 1-13. doi: 10.1056/NEJMoa2001282. [Epub ahead of print].
37. World Health Organization (WHO). Coronavirus disease (COVID-19) advice for the public: When and how to use masks, 2020. https://www.who.int/emergencies/diseases/novelcoronavirus-2019/advice-for-public/when-and-how-to-usemasks. (Erişim Tarihi: 02.04.2020).
38. Millar RC. Journal of Evidence-based Nursing Practice. J Evidence-based Nurs Prac, 2020; 1 (1), 4-8.
39. Centers for Disease Control and Prevention (CDC). Environmental Infection Control Guidelines. Ventilation Specifications: Table B.3. Pressure relationships and ventilation of certain areas of nursing facilities, 2020. https://www.cdc.gov/infectioncontrol/guidelines/environmental /appendix/air.html#tableb3. (Erişim Tarihi: 30.03.2020). 4 0. Li J for Quartz. China is being accused of mistreating coronavirus nurses for propaganda, 2020. https://qz.com/1804040/chinas-coverage-of-coronavirusnurses-provokes-backlash/. (Erişim Tarihi: 01.04.2020).

APA	demirağ h, HİNTİSTAN s (2020). COVID-19’un Klinik Yönetimi ve Hemşirelik. , 222 - 231.
Chicago	demirağ hatice,HİNTİSTAN sevilay COVID-19’un Klinik Yönetimi ve Hemşirelik. (2020): 222 - 231.
MLA	demirağ hatice,HİNTİSTAN sevilay COVID-19’un Klinik Yönetimi ve Hemşirelik. , 2020, ss.222 - 231.
AMA	demirağ h,HİNTİSTAN s COVID-19’un Klinik Yönetimi ve Hemşirelik. . 2020; 222 - 231.
Vancouver	demirağ h,HİNTİSTAN s COVID-19’un Klinik Yönetimi ve Hemşirelik. . 2020; 222 - 231.
IEEE	demirağ h,HİNTİSTAN s "COVID-19’un Klinik Yönetimi ve Hemşirelik." , ss.222 - 231, 2020.
ISNAD	demirağ, hatice - HİNTİSTAN, sevilay. "COVID-19’un Klinik Yönetimi ve Hemşirelik". (2020), 222-231.

APA	demirağ h, HİNTİSTAN s (2020). COVID-19’un Klinik Yönetimi ve Hemşirelik. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, 9(2), 222 - 231.
Chicago	demirağ hatice,HİNTİSTAN sevilay COVID-19’un Klinik Yönetimi ve Hemşirelik. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi 9, no.2 (2020): 222 - 231.
MLA	demirağ hatice,HİNTİSTAN sevilay COVID-19’un Klinik Yönetimi ve Hemşirelik. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, vol.9, no.2, 2020, ss.222 - 231.
AMA	demirağ h,HİNTİSTAN s COVID-19’un Klinik Yönetimi ve Hemşirelik. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi. 2020; 9(2): 222 - 231.
Vancouver	demirağ h,HİNTİSTAN s COVID-19’un Klinik Yönetimi ve Hemşirelik. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi. 2020; 9(2): 222 - 231.
IEEE	demirağ h,HİNTİSTAN s "COVID-19’un Klinik Yönetimi ve Hemşirelik." Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, 9, ss.222 - 231, 2020.
ISNAD	demirağ, hatice - HİNTİSTAN, sevilay. "COVID-19’un Klinik Yönetimi ve Hemşirelik". Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi 9/2 (2020), 222-231.